Robert Huizinga

Robert Huizinga

Chief Executive Officer at KANE BIOTECH INC.

Net worth: 67 436 $ as of 31/05/2026

61 year
Consumer Services
Health Services
Commercial Services

Profile

Robert B. Huizinga is the founder of Renalpro.
Dr. Huizinga is Chief Executive Officer & Director at Kane Biotech, Inc. starting in 2025.
Dr. Huizinga is a Member of Sigma Theta Tau International Honor Society of Nursing, Inc. Dr. Huizinga is Principal at Reformation Consulting Services, Inc. Dr. Huizinga was Independent Director at Innovotech, Inc. from 2013 to 2016.
Dr. Huizinga was Director at Biovialife, Inc. Dr. Huizinga was Vice President-Clinical Affairs at Isotechnika Pharma, Inc. from 2002 to 2013.
Dr. Huizinga was Executive Vice President-Research at Aurinia Pharmaceuticals, Inc. from 2020 to 2022.
Dr. Huizinga earned a doctorate from Regent University.
Dr. Huizinga completed graduate studies at the University of Alberta.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/05/2026 2,932,000 ( 1.61% ) 67 436 $ 31/05/2026

Robert Huizinga active positions

CompaniesPositionStart
KANE BIOTECH INC. Chief Executive Officer 02/05/2025
Corporate Officer/Principal -

Former positions of Robert Huizinga

CompaniesPositionEnd
Director/Board Member 16/11/2024
AURINIA PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 31/10/2022
INNOVOTECH INC. Director/Board Member 08/11/2016
Chief Tech/Sci/R&D Officer 23/10/2013
Renalpro
Founder -
See the detail of Robert Huizinga's experience

Training of Robert Huizinga

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Health Services

Commercial Services

Consumer Services

Health Services

Health Technology

Health Technology

Commercial Services

Renalpro

  1. Stock Market
  2. Insiders
  3. Robert Huizinga